TREE-2: Three Regimens of Eloxatin in Advanced Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

373

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

June 30, 2005

Conditions
Colorectal Cancer
Interventions
DRUG

oxaliplatin

DRUG

fluoropyrimidine

DRUG

bevacizumab

Trial Locations (1)

08807

Sanofi-Aventis, Bridgewater

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Sanofi

INDUSTRY